Engineered Conotoxin Differentially Blocks and Discriminates Rat and Human α7 Nicotinic Acetylcholine Receptors

Area of Science:

• Neuroscience
• Pharmacology
• Biochemistry

Background:

• The α7 nicotinic acetylcholine receptor (nAChR) is crucial for cognitive functions and memory.
• α-Conotoxin LvIB is a peptide toxin derived from *Conus lividus*.

Purpose of the Study:

• To synthesize and screen α-conotoxin analogues for activity against various nAChR subtypes.
• To investigate the species selectivity of a potent α7 nAChR blocker.

Main Methods:

• Synthesis of α-conotoxin LvIB isomers and analogues.
• Screening of synthesized peptides against nAChR subtypes.
• Site-directed mutagenesis to identify key residues for receptor interaction.

Main Results:

• An amidated analogue, [Q1G,ΔR14]LvIB, potently inhibited rat α7 nAChRs (IC50: 97 nM).
• This analogue exhibited significant selectivity, with a weaker effect on human α7 nAChRs (IC50: 1570 nM).
• Combined mutations at Gln141, Asn184, and Lys186 were essential for determining species specificity.

Conclusions:

• Engineered conotoxins can be designed to selectively target specific nAChR subtypes.
• The findings provide a basis for developing novel therapeutic agents for neurological disorders involving α7 nAChRs.